Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Steiger

Showing results (81-90 of 208) with videos related to

Pageof 21
Sort By:
Pharmacopsychiatry|September 16, 2010
Nocturnal administration of ghrelin does not promote memory consolidationM Dresler, M Kluge, L Genzel, et al.
Neuropsychobiology|August 14, 1998
Effects of thyrotropin-releasing hormone on the sleep EEG and nocturnal hormone secretion in male volunteersU Hemmeter, B Rothe, J Guldner, et al.
Journal of Neuroendocrinology|March 1, 1997
Changes in sleep-endocrine activity after growth hormone-releasing hormone depend on time of administrationT Schier, J Guldner, M Colla, et al.
Journal of Neuroendocrinology|May 21, 1999
Effects of growth hormone-releasing peptide-6 on the nocturnal secretion of GH, ACTH and cortisol and on the sleep EEG in man: role of routes of administrationR M Frieboes, H Murck, I A Antonijevic, et al.
Acta Crystallographica. Section E, Crystallographic Communications|February 20, 2020
Synthesis and crystal structures of a bis-(3-hy-droxy-cyclo-hex-2-en-1-one) and two hexa-hydro-quinoline derivativesScott A Steiger, Chun Li, Christina Gates, et al.
Journal of Psychiatric Research|October 9, 2012
The interaction between sleep quality and academic performanceK Ahrberg, M Dresler, S Niedermaier, et al.
Psychopharmacology|June 13, 2001
Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A agonist EMD 68843 on the sleep EEG in healthy menH Murck, R M Frieboes, I A Antonijevic, et al.
Nano Letters|August 12, 2010
Anomalous piezoresistance effect in ultrastrained silicon nanowiresA Lugstein, M Steinmair, A Steiger, et al.
Pharmacopsychiatry|November 1, 1987
Results of an open clinical trial of brofaromine (CGP 11 305 A), a competitive, selective, and short-acting inhibitor of MAO-A in major endogenous depressionA Steiger, F Holsboer, A Gerken, et al.
Journal of the American Geriatrics Society|February 1, 1985
Effects of naloxone in treatment of senile dementiaW A Steiger, M Mendelson, T Jenkins, et al.
Pageof 21

Showing results (81-90 of 208) with videos related to

Sort By:
Pageof 21
Pharmacopsychiatry|September 16, 2010
Nocturnal administration of ghrelin does not promote memory consolidationM Dresler, M Kluge, L Genzel, et al.
Neuropsychobiology|August 14, 1998
Effects of thyrotropin-releasing hormone on the sleep EEG and nocturnal hormone secretion in male volunteersU Hemmeter, B Rothe, J Guldner, et al.
Journal of Neuroendocrinology|March 1, 1997
Changes in sleep-endocrine activity after growth hormone-releasing hormone depend on time of administrationT Schier, J Guldner, M Colla, et al.
Journal of Neuroendocrinology|May 21, 1999
Effects of growth hormone-releasing peptide-6 on the nocturnal secretion of GH, ACTH and cortisol and on the sleep EEG in man: role of routes of administrationR M Frieboes, H Murck, I A Antonijevic, et al.
Acta Crystallographica. Section E, Crystallographic Communications|February 20, 2020
Synthesis and crystal structures of a bis-(3-hy-droxy-cyclo-hex-2-en-1-one) and two hexa-hydro-quinoline derivativesScott A Steiger, Chun Li, Christina Gates, et al.
Journal of Psychiatric Research|October 9, 2012
The interaction between sleep quality and academic performanceK Ahrberg, M Dresler, S Niedermaier, et al.
Psychopharmacology|June 13, 2001
Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A agonist EMD 68843 on the sleep EEG in healthy menH Murck, R M Frieboes, I A Antonijevic, et al.
Nano Letters|August 12, 2010
Anomalous piezoresistance effect in ultrastrained silicon nanowiresA Lugstein, M Steinmair, A Steiger, et al.
Pharmacopsychiatry|November 1, 1987
Results of an open clinical trial of brofaromine (CGP 11 305 A), a competitive, selective, and short-acting inhibitor of MAO-A in major endogenous depressionA Steiger, F Holsboer, A Gerken, et al.
Journal of the American Geriatrics Society|February 1, 1985
Effects of naloxone in treatment of senile dementiaW A Steiger, M Mendelson, T Jenkins, et al.
Pageof 21